Technology News and Research

RSS

New generation of lenses makes evolutionary leap in eliminating need for glasses

The need for reading glasses or bifocals as we age may begin fading from sight with the latest generation of intraocular lenses.

3 Jun 2005

Gene research may help explain how adorable children become surly teenagers

University of Utah researchers showed that a fruit fly gene is crucial for determining when juveniles begin to mature into adults, and how the transformation initially proceeds. Understanding this process in humans may help explain how adorable children become surly teenagers.

3 Jun 2005

High-tech imaging software locates more accurately the abnormal electrical impulses that produce heart arrhythmias

Loyola University Health System is one of the first hospitals in the United States to employ new high-tech imaging software - in conjunction with a three-dimensional cardiac mapping and navigation system - to locate more accurately the abnormal electrical impulses that produce heart rhythm disturbances (arrhythmias). This technology represents a major breakthrough in treating complex arrhythmias.

3 Jun 2005

Exposure to aflatoxins that contaminate crops in developing countries can be reduced by a simple, cost-effective intervention

Exposure to a cancer-causing toxin that contaminates crops in developing countries can be reduced by a simple, cost-effective intervention on post-harvest storage, concludes a study in this week’s issue of The Lancet.

3 Jun 2005

Children living close to high voltage overhead power lines at birth may be at an increased risk of leukaemia

The electric power system produces extremely low frequency electric and magnetic fields, and since 1979 there has been concern that these fields may be associated with cancer. In 2001, the International Agency for Research on Cancer classified extremely low frequency magnetic fields as "possibly carcinogenic" while others, such as the UK Childhood Cancer Study, dispute the risk.

3 Jun 2005

Novel strategy proves highly effective in killing drug-resistant multiple myeloma cells

A novel strategy devised by Dana-Farber Cancer Institute scientists has proved highly effective in killing drug-resistant multiple myeloma cells in the laboratory and could open a new form of attack on the deadly blood cancer, they report.

2 Jun 2005

Choose life: putting some extra marketing spin on public health

Researchers at the University of Technology, Sydney will use their expertise in modelling what people want to tackle the serious problem of obesity.

1 Jun 2005

Scientists develop a way to block the signals responsible for neuropathic pain

Remember how it felt the last time you burned your finger on a hot stove? Imagine what it's like to have that burning pain in your hands or feet all the time and know there's virtually nothing you can do about it.

1 Jun 2005

Genesis Bioventures signs agreement for control of Mad Cow diagnostic company

Further to a Letter of Intent previously reported, Genesis Bioventures today announced that it has entered into a binding agreement with Efoora Inc. and Prion Developmental Laboratories, Inc. to buy all of Efoora's majority interest shares owned or pledged in PDL thereby gaining controlling interest of PDL. A Form 8-K has been filed with the SEC in this regard. Prior to the Agreement, GBI had one-third equity interest in PDL.

1 Jun 2005

Diagnostic test for Lou Gehrig's disease

Bowser is director of the ALS Tissue Bank and an Associate Professor of Pathology at the University of Pittsburgh School of Medicine who is using a key piece of biomarker discovery equipment known as SELDI to find new ways to identify and eventually treat Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease.

1 Jun 2005

Hybridon collaborates to develop immune modulatory (IMO) compounds for asthma and allergy

Hybridon today announced it had entered into research collaboration and license agreements with Novartis for the discovery, optimization, development and commercialization of Toll-like receptor 9 (TLR9) drug candidates targeting asthma and allergy based on Hybridon's proprietary immune modulatory oligonucleotide (IMO) technology platform.

1 Jun 2005

Is there a link between cell phones and brain tumors?

Is there a link between cell phones and brain tumors? Over the past 15 years, there has been growing concern about this possibility. Part of this concern stems from the fact that there are over one billion cell phone subscribers worldwide, and the number is increasing.

31 May 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

Nastech Pharmaceutical awarded new breast cancer patent

Nastech Pharmaceutical Company today announced that it has been awarded U.S. patent No. 6,894,026, entitled, "Long-acting Oxytocin Analogues for the Treatment and Prevention of Breast Cancer and Psychiatric Disorders."

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

Those old crooners were right, love really can make you crazy

According to scientists brain images show that falling in love can look for all the world like mental illness with a mixture of mania, dementia and obsession that cuts people off from friends and family prompting uncharacteristic behavior which could almost be mistaken for psychosis.

31 May 2005

Artificial cobweb proteins for medicine

A unique material based on cobweb proteins is being created by Russian researchers of the State Research Center of Russian Federation GosNIIgentics, Scientific Research Center “Coal-Chemical Fiber”, State Research Center of Applied Microbiology in cooperation with their colleagues from Michigan University with support form the International Science and Technology Center (ISTC) (project 1033.2).

30 May 2005

Targeted Genetics issued patent related to adeno-associated virus (AAV) technology platform

Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.

30 May 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005

Technology for analyzing gene expression must be standardized

Technology for analyzing gene expression must be standardized among laboratories and across platforms around the world to support this age of human genome exploration, an Oregon Health & Science University researcher says.

29 May 2005

Technology News and Research

New generation of lenses makes evolutionary leap in eliminating need for glasses

Gene research may help explain how adorable children become surly teenagers

High-tech imaging software locates more accurately the abnormal electrical impulses that produce heart arrhythmias

Exposure to aflatoxins that contaminate crops in developing countries can be reduced by a simple, cost-effective intervention

Children living close to high voltage overhead power lines at birth may be at an increased risk of leukaemia

Novel strategy proves highly effective in killing drug-resistant multiple myeloma cells

Choose life: putting some extra marketing spin on public health

Scientists develop a way to block the signals responsible for neuropathic pain

Genesis Bioventures signs agreement for control of Mad Cow diagnostic company

Diagnostic test for Lou Gehrig's disease

Hybridon collaborates to develop immune modulatory (IMO) compounds for asthma and allergy

Is there a link between cell phones and brain tumors?

New approach to inhibiting blood vessel growth or angiogenesis

Nastech Pharmaceutical awarded new breast cancer patent

Targepeutics issued new U.S patent

Those old crooners were right, love really can make you crazy

Artificial cobweb proteins for medicine

Targeted Genetics issued patent related to adeno-associated virus (AAV) technology platform

Bioniche Life Sciences granted European patent

Technology for analyzing gene expression must be standardized

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News